Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07269236

Prospective Real-World Study of Multimodal AI

Prospective Real-World Study of a Multimodal Artificial Intelligence Model Across Disease Types

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This project proposes to collect prospective multimodal data-such as pathology, imaging, and clinical information-and to perform integrative analyses. AI technologies can offer novel solutions for disease classification, tumor grading, histological subtyping, molecular subtyping, selection of chemotherapy regimens, risk stratification, treatment response prediction, report generation, and intelligent question-answering. This research provides important support for precision medicine and individualized treatment and has significant theoretical and practical implications. Conducting a prospective randomized controlled study better aligns with clinical application requirements and can accelerate the comprehensive deployment of AI systems.

Conditions

Timeline

Start date
2025-10-01
Primary completion
2030-09-01
Completion
2030-09-01
First posted
2025-12-08
Last updated
2025-12-08

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07269236. Inclusion in this directory is not an endorsement.